nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.107	0.136	CbGbCtD
Cefuroxime—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0956	0.121	CbGbCtD
Cefuroxime—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0924	0.117	CbGbCtD
Cefuroxime—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0852	0.108	CbGbCtD
Cefuroxime—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0824	0.104	CbGbCtD
Cefuroxime—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0813	0.103	CbGbCtD
Cefuroxime—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0734	0.0929	CbGbCtD
Cefuroxime—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.07	0.0887	CbGbCtD
Cefuroxime—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0549	0.0695	CbGbCtD
Cefuroxime—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0473	0.0599	CbGbCtD
Cefuroxime—Cefazolin—PON1—type 2 diabetes mellitus	0.000944	0.535	CrCbGaD
Cefuroxime—Cefonicid—ALB—type 2 diabetes mellitus	0.000217	0.123	CrCbGaD
Cefuroxime—Convulsion—Orlistat—type 2 diabetes mellitus	0.000147	0.000707	CcSEcCtD
Cefuroxime—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000147	0.000706	CcSEcCtD
Cefuroxime—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000147	0.000706	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000147	0.000705	CcSEcCtD
Cefuroxime—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000146	0.000703	CcSEcCtD
Cefuroxime—Chest pain—Valsartan—type 2 diabetes mellitus	0.000146	0.000703	CcSEcCtD
Cefuroxime—Sweating—Ramipril—type 2 diabetes mellitus	0.000146	0.000702	CcSEcCtD
Cefuroxime—Dizziness—Glipizide—type 2 diabetes mellitus	0.000146	0.000701	CcSEcCtD
Cefuroxime—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000146	0.0007	CcSEcCtD
Cefuroxime—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000146	0.000699	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000145	0.000698	CcSEcCtD
Cefuroxime—Angiopathy—Losartan—type 2 diabetes mellitus	0.000145	0.000696	CcSEcCtD
Cefuroxime—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000145	0.000695	CcSEcCtD
Cefuroxime—Chest pain—Orlistat—type 2 diabetes mellitus	0.000145	0.000694	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000144	0.000693	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000144	0.000689	CcSEcCtD
Cefuroxime—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000143	0.000687	CcSEcCtD
Cefuroxime—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000142	0.000683	CcSEcCtD
Cefuroxime—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000142	0.000682	CcSEcCtD
Cefuroxime—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000141	0.000677	CcSEcCtD
Cefuroxime—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000141	0.000675	CcSEcCtD
Cefuroxime—Cefradine—CYP3A4—type 2 diabetes mellitus	0.000141	0.0797	CrCbGaD
Cefuroxime—Vomiting—Glipizide—type 2 diabetes mellitus	0.000141	0.000674	CcSEcCtD
Cefuroxime—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00014	0.000674	CcSEcCtD
Cefuroxime—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00014	0.000672	CcSEcCtD
Cefuroxime—Rash—Glipizide—type 2 diabetes mellitus	0.000139	0.000669	CcSEcCtD
Cefuroxime—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000139	0.000668	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000139	0.000668	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000139	0.000668	CcSEcCtD
Cefuroxime—Erythema—Losartan—type 2 diabetes mellitus	0.000139	0.000667	CcSEcCtD
Cefuroxime—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000139	0.000666	CcSEcCtD
Cefuroxime—Headache—Glipizide—type 2 diabetes mellitus	0.000138	0.000665	CcSEcCtD
Cefuroxime—Palpitations—Metformin—type 2 diabetes mellitus	0.000138	0.000664	CcSEcCtD
Cefuroxime—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000137	0.000659	CcSEcCtD
Cefuroxime—Flatulence—Losartan—type 2 diabetes mellitus	0.000137	0.000658	CcSEcCtD
Cefuroxime—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000137	0.000657	CcSEcCtD
Cefuroxime—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000136	0.000655	CcSEcCtD
Cefuroxime—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000136	0.000654	CcSEcCtD
Cefuroxime—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000136	0.000654	CcSEcCtD
Cefuroxime—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000136	0.000653	CcSEcCtD
Cefuroxime—Agitation—Irbesartan—type 2 diabetes mellitus	0.000136	0.000652	CcSEcCtD
Cefuroxime—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000136	0.000652	CcSEcCtD
Cefuroxime—Urticaria—Glyburide—type 2 diabetes mellitus	0.000135	0.000649	CcSEcCtD
Cefuroxime—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000135	0.000648	CcSEcCtD
Cefuroxime—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000135	0.000646	CcSEcCtD
Cefuroxime—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000134	0.000645	CcSEcCtD
Cefuroxime—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000134	0.000645	CcSEcCtD
Cefuroxime—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000134	0.000643	CcSEcCtD
Cefuroxime—Anorexia—Valsartan—type 2 diabetes mellitus	0.000134	0.000642	CcSEcCtD
Cefuroxime—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000134	0.000642	CcSEcCtD
Cefuroxime—Chest pain—Metformin—type 2 diabetes mellitus	0.000133	0.00064	CcSEcCtD
Cefuroxime—Headache—Pioglitazone—type 2 diabetes mellitus	0.000133	0.000637	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000132	0.000635	CcSEcCtD
Cefuroxime—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000132	0.000635	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000132	0.000633	CcSEcCtD
Cefuroxime—Nausea—Glipizide—type 2 diabetes mellitus	0.000131	0.00063	CcSEcCtD
Cefuroxime—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000131	0.000629	CcSEcCtD
Cefuroxime—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000131	0.000627	CcSEcCtD
Cefuroxime—Pain—Gliclazide—type 2 diabetes mellitus	0.000131	0.000627	CcSEcCtD
Cefuroxime—Rash—Glimepiride—type 2 diabetes mellitus	0.00013	0.000624	CcSEcCtD
Cefuroxime—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00013	0.000624	CcSEcCtD
Cefuroxime—Rash—Sitagliptin—type 2 diabetes mellitus	0.00013	0.000622	CcSEcCtD
Cefuroxime—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000622	CcSEcCtD
Cefuroxime—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000129	0.000622	CcSEcCtD
Cefuroxime—Headache—Glimepiride—type 2 diabetes mellitus	0.000129	0.00062	CcSEcCtD
Cefuroxime—Cough—Irbesartan—type 2 diabetes mellitus	0.000129	0.000619	CcSEcCtD
Cefuroxime—Headache—Sitagliptin—type 2 diabetes mellitus	0.000129	0.000618	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000128	0.000614	CcSEcCtD
Cefuroxime—Agitation—Losartan—type 2 diabetes mellitus	0.000128	0.000613	CcSEcCtD
Cefuroxime—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000611	CcSEcCtD
Cefuroxime—Angioedema—Losartan—type 2 diabetes mellitus	0.000127	0.00061	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000126	0.000606	CcSEcCtD
Cefuroxime—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000126	0.000604	CcSEcCtD
Cefuroxime—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000126	0.000604	CcSEcCtD
Cefuroxime—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000125	0.000602	CcSEcCtD
Cefuroxime—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000125	0.000601	CcSEcCtD
Cefuroxime—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000125	0.0006	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000125	0.0006	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000125	0.000599	CcSEcCtD
Cefuroxime—Somnolence—Valsartan—type 2 diabetes mellitus	0.000125	0.000599	CcSEcCtD
Cefuroxime—Leukopenia—Losartan—type 2 diabetes mellitus	0.000124	0.000597	CcSEcCtD
Cefuroxime—Skin disorder—Metformin—type 2 diabetes mellitus	0.000124	0.000596	CcSEcCtD
Cefuroxime—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000124	0.000594	CcSEcCtD
Cefuroxime—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000124	0.000593	CcSEcCtD
Cefuroxime—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000124	0.000593	CcSEcCtD
Cefuroxime—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000123	0.000591	CcSEcCtD
Cefuroxime—Palpitations—Losartan—type 2 diabetes mellitus	0.000123	0.00059	CcSEcCtD
Cefuroxime—Nausea—Glimepiride—type 2 diabetes mellitus	0.000122	0.000588	CcSEcCtD
Cefuroxime—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000586	CcSEcCtD
Cefuroxime—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000122	0.000586	CcSEcCtD
Cefuroxime—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000122	0.000585	CcSEcCtD
Cefuroxime—Anorexia—Metformin—type 2 diabetes mellitus	0.000122	0.000585	CcSEcCtD
Cefuroxime—Cough—Losartan—type 2 diabetes mellitus	0.000121	0.000582	CcSEcCtD
Cefuroxime—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000121	0.000582	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000121	0.000581	CcSEcCtD
Cefuroxime—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000121	0.00058	CcSEcCtD
Cefuroxime—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000121	0.00058	CcSEcCtD
Cefuroxime—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000121	0.000579	CcSEcCtD
Cefuroxime—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000121	0.000579	CcSEcCtD
Cefuroxime—Pruritus—Glyburide—type 2 diabetes mellitus	0.00012	0.000578	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00012	0.000575	CcSEcCtD
Cefuroxime—Erythema—Ramipril—type 2 diabetes mellitus	0.000119	0.000572	CcSEcCtD
Cefuroxime—Pain—Orlistat—type 2 diabetes mellitus	0.000119	0.000569	CcSEcCtD
Cefuroxime—Arthralgia—Losartan—type 2 diabetes mellitus	0.000118	0.000568	CcSEcCtD
Cefuroxime—Chest pain—Losartan—type 2 diabetes mellitus	0.000118	0.000568	CcSEcCtD
Cefuroxime—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000568	CcSEcCtD
Cefuroxime—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000567	CcSEcCtD
Cefuroxime—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000565	CcSEcCtD
Cefuroxime—Rash—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000563	CcSEcCtD
Cefuroxime—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000563	CcSEcCtD
Cefuroxime—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000117	0.000562	CcSEcCtD
Cefuroxime—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000117	0.00056	CcSEcCtD
Cefuroxime—Headache—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000559	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000116	0.000559	CcSEcCtD
Cefuroxime—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000116	0.000559	CcSEcCtD
Cefuroxime—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000115	0.000552	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000115	0.000551	CcSEcCtD
Cefuroxime—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000115	0.00055	CcSEcCtD
Cefuroxime—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000114	0.000547	CcSEcCtD
Cefuroxime—Somnolence—Metformin—type 2 diabetes mellitus	0.000114	0.000545	CcSEcCtD
Cefuroxime—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000113	0.000545	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000113	0.000544	CcSEcCtD
Cefuroxime—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000113	0.00054	CcSEcCtD
Cefuroxime—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000112	0.00054	CcSEcCtD
Cefuroxime—Urticaria—Valsartan—type 2 diabetes mellitus	0.000111	0.000535	CcSEcCtD
Cefuroxime—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000111	0.000533	CcSEcCtD
Cefuroxime—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000111	0.000533	CcSEcCtD
Cefuroxime—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000111	0.000532	CcSEcCtD
Cefuroxime—Tachycardia—Losartan—type 2 diabetes mellitus	0.000111	0.000532	CcSEcCtD
Cefuroxime—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000111	0.00053	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00011	0.00053	CcSEcCtD
Cefuroxime—Urticaria—Orlistat—type 2 diabetes mellitus	0.00011	0.000529	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00011	0.000527	CcSEcCtD
Cefuroxime—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00011	0.000527	CcSEcCtD
Cefuroxime—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00011	0.000526	CcSEcCtD
Cefuroxime—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00011	0.000526	CcSEcCtD
Cefuroxime—Agitation—Ramipril—type 2 diabetes mellitus	0.00011	0.000526	CcSEcCtD
Cefuroxime—Angioedema—Ramipril—type 2 diabetes mellitus	0.000109	0.000523	CcSEcCtD
Cefuroxime—Anorexia—Losartan—type 2 diabetes mellitus	0.000108	0.000519	CcSEcCtD
Cefuroxime—Vomiting—Glyburide—type 2 diabetes mellitus	0.000108	0.000519	CcSEcCtD
Cefuroxime—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000108	0.000519	CcSEcCtD
Cefuroxime—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000108	0.000516	CcSEcCtD
Cefuroxime—Rash—Glyburide—type 2 diabetes mellitus	0.000107	0.000515	CcSEcCtD
Cefuroxime—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000107	0.000515	CcSEcCtD
Cefuroxime—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000107	0.000514	CcSEcCtD
Cefuroxime—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000107	0.000512	CcSEcCtD
Cefuroxime—Headache—Glyburide—type 2 diabetes mellitus	0.000107	0.000511	CcSEcCtD
Cefuroxime—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000106	0.00051	CcSEcCtD
Cefuroxime—Palpitations—Ramipril—type 2 diabetes mellitus	0.000105	0.000506	CcSEcCtD
Cefuroxime—Cefazolin—ALB—type 2 diabetes mellitus	0.000105	0.0596	CrCbGaD
Cefuroxime—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000105	0.000503	CcSEcCtD
Cefuroxime—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000104	0.000502	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000104	0.000502	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.0005	CcSEcCtD
Cefuroxime—Cough—Ramipril—type 2 diabetes mellitus	0.000104	0.000499	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000103	0.000496	CcSEcCtD
Cefuroxime—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000103	0.000496	CcSEcCtD
Cefuroxime—Convulsion—Ramipril—type 2 diabetes mellitus	0.000103	0.000496	CcSEcCtD
Cefuroxime—Pain—Irbesartan—type 2 diabetes mellitus	0.000103	0.000495	CcSEcCtD
Cefuroxime—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000102	0.00049	CcSEcCtD
Cefuroxime—Urticaria—Metformin—type 2 diabetes mellitus	0.000102	0.000487	CcSEcCtD
Cefuroxime—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000102	0.000487	CcSEcCtD
Cefuroxime—Chest pain—Ramipril—type 2 diabetes mellitus	0.000102	0.000487	CcSEcCtD
Cefuroxime—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000101	0.000486	CcSEcCtD
Cefuroxime—Nausea—Glyburide—type 2 diabetes mellitus	0.000101	0.000485	CcSEcCtD
Cefuroxime—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000101	0.000485	CcSEcCtD
Cefuroxime—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000101	0.000485	CcSEcCtD
Cefuroxime—Somnolence—Losartan—type 2 diabetes mellitus	0.000101	0.000484	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000101	0.000484	CcSEcCtD
Cefuroxime—Dyspepsia—Losartan—type 2 diabetes mellitus	9.99e-05	0.000479	CcSEcCtD
Cefuroxime—Ceftriaxone—ALB—type 2 diabetes mellitus	9.96e-05	0.0565	CrCbGaD
Cefuroxime—Pruritus—Valsartan—type 2 diabetes mellitus	9.93e-05	0.000477	CcSEcCtD
Cefuroxime—Decreased appetite—Losartan—type 2 diabetes mellitus	9.86e-05	0.000474	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.86e-05	0.000473	CcSEcCtD
Cefuroxime—Pruritus—Orlistat—type 2 diabetes mellitus	9.81e-05	0.000471	CcSEcCtD
Cefuroxime—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000467	CcSEcCtD
Cefuroxime—Vomiting—Gliclazide—type 2 diabetes mellitus	9.71e-05	0.000466	CcSEcCtD
Cefuroxime—Pain—Losartan—type 2 diabetes mellitus	9.7e-05	0.000466	CcSEcCtD
Cefuroxime—Rash—Gliclazide—type 2 diabetes mellitus	9.63e-05	0.000462	CcSEcCtD
Cefuroxime—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.62e-05	0.000462	CcSEcCtD
Cefuroxime—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.6e-05	0.000461	CcSEcCtD
Cefuroxime—Urticaria—Irbesartan—type 2 diabetes mellitus	9.58e-05	0.00046	CcSEcCtD
Cefuroxime—Headache—Gliclazide—type 2 diabetes mellitus	9.57e-05	0.000459	CcSEcCtD
Cefuroxime—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.53e-05	0.000458	CcSEcCtD
Cefuroxime—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.53e-05	0.000458	CcSEcCtD
Cefuroxime—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.53e-05	0.000457	CcSEcCtD
Cefuroxime—Tachycardia—Ramipril—type 2 diabetes mellitus	9.5e-05	0.000456	CcSEcCtD
Cefuroxime—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.49e-05	0.000455	CcSEcCtD
Cefuroxime—Skin disorder—Ramipril—type 2 diabetes mellitus	9.45e-05	0.000454	CcSEcCtD
Cefuroxime—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.41e-05	0.000452	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.28e-05	0.000445	CcSEcCtD
Cefuroxime—Dizziness—Valsartan—type 2 diabetes mellitus	9.28e-05	0.000445	CcSEcCtD
Cefuroxime—Anorexia—Ramipril—type 2 diabetes mellitus	9.27e-05	0.000445	CcSEcCtD
Cefuroxime—Dizziness—Orlistat—type 2 diabetes mellitus	9.17e-05	0.00044	CcSEcCtD
Cefuroxime—Cephalexin—CYP3A4—type 2 diabetes mellitus	9.09e-05	0.0515	CrCbGaD
Cefuroxime—Nausea—Gliclazide—type 2 diabetes mellitus	9.07e-05	0.000435	CcSEcCtD
Cefuroxime—Pruritus—Metformin—type 2 diabetes mellitus	9.04e-05	0.000434	CcSEcCtD
Cefuroxime—Urticaria—Losartan—type 2 diabetes mellitus	9.01e-05	0.000433	CcSEcCtD
Cefuroxime—Abdominal pain—Losartan—type 2 diabetes mellitus	8.97e-05	0.000431	CcSEcCtD
Cefuroxime—Body temperature increased—Losartan—type 2 diabetes mellitus	8.97e-05	0.000431	CcSEcCtD
Cefuroxime—Vomiting—Valsartan—type 2 diabetes mellitus	8.92e-05	0.000428	CcSEcCtD
Cefuroxime—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.88e-05	0.000426	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.86e-05	0.000426	CcSEcCtD
Cefuroxime—Rash—Valsartan—type 2 diabetes mellitus	8.85e-05	0.000425	CcSEcCtD
Cefuroxime—Dermatitis—Valsartan—type 2 diabetes mellitus	8.84e-05	0.000424	CcSEcCtD
Cefuroxime—Vomiting—Orlistat—type 2 diabetes mellitus	8.82e-05	0.000423	CcSEcCtD
Cefuroxime—Headache—Valsartan—type 2 diabetes mellitus	8.79e-05	0.000422	CcSEcCtD
Cefuroxime—Diarrhoea—Metformin—type 2 diabetes mellitus	8.74e-05	0.00042	CcSEcCtD
Cefuroxime—Rash—Orlistat—type 2 diabetes mellitus	8.74e-05	0.00042	CcSEcCtD
Cefuroxime—Dermatitis—Orlistat—type 2 diabetes mellitus	8.73e-05	0.000419	CcSEcCtD
Cefuroxime—Cefalotin—ALB—type 2 diabetes mellitus	8.73e-05	0.0495	CrCbGaD
Cefuroxime—Headache—Orlistat—type 2 diabetes mellitus	8.69e-05	0.000417	CcSEcCtD
Cefuroxime—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.67e-05	0.000416	CcSEcCtD
Cefuroxime—Somnolence—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000415	CcSEcCtD
Cefuroxime—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.57e-05	0.000411	CcSEcCtD
Cefuroxime—Pruritus—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.00041	CcSEcCtD
Cefuroxime—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.46e-05	0.000406	CcSEcCtD
Cefuroxime—Dizziness—Metformin—type 2 diabetes mellitus	8.45e-05	0.000406	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000403	CcSEcCtD
Cefuroxime—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.36e-05	0.000401	CcSEcCtD
Cefuroxime—Nausea—Valsartan—type 2 diabetes mellitus	8.33e-05	0.0004	CcSEcCtD
Cefuroxime—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.25e-05	0.000396	CcSEcCtD
Cefuroxime—Nausea—Orlistat—type 2 diabetes mellitus	8.24e-05	0.000395	CcSEcCtD
Cefuroxime—Vomiting—Metformin—type 2 diabetes mellitus	8.12e-05	0.00039	CcSEcCtD
Cefuroxime—Rash—Metformin—type 2 diabetes mellitus	8.06e-05	0.000387	CcSEcCtD
Cefuroxime—Dermatitis—Metformin—type 2 diabetes mellitus	8.05e-05	0.000386	CcSEcCtD
Cefuroxime—Pruritus—Losartan—type 2 diabetes mellitus	8.03e-05	0.000385	CcSEcCtD
Cefuroxime—Headache—Metformin—type 2 diabetes mellitus	8e-05	0.000384	CcSEcCtD
Cefuroxime—Dizziness—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000383	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000382	CcSEcCtD
Cefuroxime—Cephalexin—ALB—type 2 diabetes mellitus	7.93e-05	0.045	CrCbGaD
Cefuroxime—Diarrhoea—Losartan—type 2 diabetes mellitus	7.76e-05	0.000373	CcSEcCtD
Cefuroxime—Urticaria—Ramipril—type 2 diabetes mellitus	7.73e-05	0.000371	CcSEcCtD
Cefuroxime—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000369	CcSEcCtD
Cefuroxime—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000369	CcSEcCtD
Cefuroxime—Vomiting—Irbesartan—type 2 diabetes mellitus	7.67e-05	0.000368	CcSEcCtD
Cefuroxime—Rash—Irbesartan—type 2 diabetes mellitus	7.6e-05	0.000365	CcSEcCtD
Cefuroxime—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.6e-05	0.000365	CcSEcCtD
Cefuroxime—Nausea—Metformin—type 2 diabetes mellitus	7.59e-05	0.000364	CcSEcCtD
Cefuroxime—Headache—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000363	CcSEcCtD
Cefuroxime—Dizziness—Losartan—type 2 diabetes mellitus	7.5e-05	0.00036	CcSEcCtD
Cefuroxime—Vomiting—Losartan—type 2 diabetes mellitus	7.21e-05	0.000346	CcSEcCtD
Cefuroxime—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000344	CcSEcCtD
Cefuroxime—Nausea—Irbesartan—type 2 diabetes mellitus	7.16e-05	0.000344	CcSEcCtD
Cefuroxime—Rash—Losartan—type 2 diabetes mellitus	7.15e-05	0.000343	CcSEcCtD
Cefuroxime—Dermatitis—Losartan—type 2 diabetes mellitus	7.15e-05	0.000343	CcSEcCtD
Cefuroxime—Headache—Losartan—type 2 diabetes mellitus	7.11e-05	0.000341	CcSEcCtD
Cefuroxime—Pruritus—Ramipril—type 2 diabetes mellitus	6.88e-05	0.00033	CcSEcCtD
Cefuroxime—Nausea—Losartan—type 2 diabetes mellitus	6.74e-05	0.000324	CcSEcCtD
Cefuroxime—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.66e-05	0.00032	CcSEcCtD
Cefuroxime—Dizziness—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000309	CcSEcCtD
Cefuroxime—Vomiting—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000297	CcSEcCtD
Cefuroxime—Rash—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000295	CcSEcCtD
Cefuroxime—Dermatitis—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000294	CcSEcCtD
Cefuroxime—Headache—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000293	CcSEcCtD
Cefuroxime—Nausea—Ramipril—type 2 diabetes mellitus	5.78e-05	0.000277	CcSEcCtD
